Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Varenicline and CV events: postmarketing experience in NZ

    • 13 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Harrison-Woolrych M, Maggo S, Tan M, Savage R, Ashton J.Cardiovascular events in patients taking varenicline: a case series from intensive post-marketing surveillance in New Zealand. Drug Safety 35: 33-43, No. 1, 2012

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Varenicline and CV events: postmarketing experience in NZ. React. Wkly. 1383, 5 (2012). https://doi.org/10.2165/00128415-201213830-00015

    Download citation

    Keywords

    • Smoking Cessation
    • Myocardial Ischaemia
    • Varenicline
    • Cerebrovascular Event
    • Hypotensive Event